| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



* Department of Biological Sciences and Biotechnology,
State Key Laboratory of Biomembrane and Membrane Biotechnology, and
Protein Science Laboratory of MOE, Tsinghua University, Beijing 100084, Peoples Republic of China
Correspondence: Address reprint requests to Dr. Yong-Bin Yan, Dept. of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, PR China. Fax: 86-10-6277-1597; E-mail: ybyan{at}tsinghua.edu.cn; or Dr. Hai-Meng Zhou, Fax: 86-10-6277-2245; E-mail: zhm-dbs{at}tsinghua.edu.cn.
| ABSTRACT |
|---|
|
|
|---|
-, ß-, and
-CD, were used to investigate the molecular mechanism of their effects on assisting aminoacylase refolding. The aggregation and reactivation experiments suggested that at moderate concentrations, HPCDs could suppress aggregation and assist aminoacylase refolding in a concentration-dependent manner, and HP-ß-CD was the most efficient of the three HPCDs. Low concentrations of HP-
-CD and high concentrations of HP-
-CD promoted off-pathway aggregation. Spectroscopic studies indicated that the hydrophobic exposure of the unstructured species in the refolded solutions was gradually reduced by the three HPCDs with the efficiency HP-ß-CD > HP-
-CD > HP-
-CD. Furthermore, the fast phase of aminoacylase reactivation was slowed down by the addition of 75 mM HP-ß- and
-CD, but no significant effect was observed for HP-
-CD. The dissimilarity in the effects of the three HPCDs suggested that the internal cavity size played a crucial role in their antiaggregation ability. Further analysis suggested that the observations might be much more complicated than expected because of the various types of interactions between cyclodextrins and proteins in addition to their ability to bind to protein aromatic residues. | INTRODUCTION |
|---|
|
|
|---|
Cyclodextrin is a water-soluble, nontoxic, stable, circular oligosaccharide composed of
-(1
,4
)-linked
-D-glucosyl units. The structure of cyclodextrin is cylinder shaped with hydrophilic rims outside where OH-6 is on the narrow rim and OH-2 and OH-3 are on the wide rim. The interior, where H-3, H-5, and H-6 hydrogens and O-4 ether-like oxygens are located, forms a hydrophobic cavity (13
). The exterior polar groups help cyclodextrin to dissolve in water, whereas the central nonpolar cavity enables it to interact with the hydrophobic residues of proteins or drugs. The most common types of cyclodextrin are
-, ß-, and
-cyclodextrin, which consist of six, seven, and eight glucosyl units. The more glucose units in the cyclodextrin circle, the larger the cavity (13
). Natural cyclodextrins have rather limited solubility in water (14
), and various derivatives have been synthesized to improve its solubility (15
). Cyclodextrins as well as their chemically modified variants have been widely used in pharmaceuticals as drug carriers (14
,16
). The properties of cyclodextrin also make it an ideal additive to prevent proteins from sticking together during refolding (17
21
).
Aminoacylase (N-acyl-L-amino acid amido hydrolase, EC 3.5.1.14), which exists in mammalian kidneys and in many microorganisms, is an important enzyme participating in amino acid metabolism in organisms (22
25
). The unfolding of aminoacylase has been thoroughly studied (26
30
), whereas the refolding and reactivation of aminoacylase has always failed due to serious aggregation (26
,27
,30
). The refolding of aminoacylase was thought to be irreversible for a long time, until recently, when it was shown that the reactivation of aminoacylase could be successful under low concentrations and low temperature conditions (7
). Thus aminoacylase is a good model to test the effect of various refolding-enhancing strategies including the addition of cyclodextrins. In this work, the effects of hydroxypropyl cyclodextrins (HPCDs) on the inhibition of aggregation and the promotion of refolding were studied by using guanidine hydrochloride (GdHCl)-denatured aminoacylase as a model system. It was found that aminoacylase refolding could be promoted significantly by the addition of HPCDs in the dilution buffer. Moreover, it was also of interest to find that the hydroxypropyl
-, ß-, and
-cyclodextrins (HP-
-CD, HP-ß-CD, HP-
-CD, respectively) have quite different abilities in assisting the refolding of aminoacylase in vitro. The main difference among these three HPCDs is the size of the cavity, and thus the different behavior of the three HPCDs helps us to understand the structure-activity relationship of cyclodextrins. The results herein also provide clues in designing improved cyclodextrin-based antiaggregation agents.
| MATERIALS AND METHODS |
|---|
|
|
|---|
-cyclodextrin (HP-
-CD) was a Fluka (Milwaukee, WI) product, and hydroxypropyl-ß-cyclodextrin (HP-ß-CD) and hydroxypropyl-
-cyclodextrin (HP-
-CD) were Acros (Somerville, NJ) products. Ultrapure grade GdHCl, chloroacetyl-L-leucine, SDS, and 8-anilino-1-naphthalenesulfonate (ANS) were purchased from Sigma (St. Louis, MO). All other reagents were local products of analytical grade.
Binding of HPCDs to free Trp
The binding ability of the three HPCDs to free Trp was monitored by intrinsic fluorescence on an F-2500 fluorescence spectrophotometer using 1-cm path-length cuvettes with an excitation wavelength of 280 nm at 25°C. The fluorescence spectra over a wavelength range of 300600 nm were measured for 0.25 mM Trp in 30 mM Tris-HCl buffer with or without the addition of 10 mM HPCDs. The concentration-dependent effect of HP-ß-CD on the fluorescence spectra of Trp was studied by ranging the concentration of HP-ß-CD from 0.5 to 75 mM with a Trp concentration of 0.1 mM. The fitting of the fluorescence spectra was carried out using the discrete states model as described previously (31
,32
).
Aminoacylase activity assay
The enzyme concentration was determined by measuring the absorbance at 280 nm and using the absorption coefficient
(24
). Enzyme activity was determined at 25°C by measuring the absorbance at 238 nm accompanied with hydrolysis of the substrate and using the molar absorption coefficient
238 = 185 M1cm1 as reported by Kordel and Schneider (24
,25
) except that chloroacetyl-L-leucine was used instead of pure L-enantionmorph. The reaction system was prepared by mixing 10 µl of 1 µM enzyme to 0.5 ml of substrate medium.
Spectroscopy measurements
Aminoacylase was denatured in 30 mM Tris-HCl buffer, pH 7.5, containing 4 M GdHCl. The solution was incubated overnight at 25°C before refolding experiments were carried out. The denatured aminoacylase (60 µM) was diluted 60-fold into the refolding buffer (30 mM Tris-HCl, pH 7.5) containing various concentrations of HPCDs and refolded at 4°C for 24 h. Then the samples were used for all biospectroscopy studies except for aggregation experiments. All experiments were repeated three to four times to ensure the reproducibility of the data.
Emission fluorescence spectra were recorded with an F-2500 fluorescence spectrophotometer using 1-cm path-length cuvettes at 4°C. An excitation wavelength of 295 nm was used to measure the intrinsic fluorescence of aminoacylase Trp. Far-ultraviolet circular dichroism (CD) spectra were measured on a Jasco (Tokyo, Japan) 715 spectropolarimeter with a 1-mm path-length cell over a wavelength range of 200250 nm. The final enzyme concentration was 1 µM for fluorescence and CD experiments.
For aggregation measurements, the denatured aminoacylase (60 or 120 µM) was diluted 60-fold into refolding buffer (30 mM Tris-HCl, pH 7.5) containing various concentrations of HPCDs. The final enzyme concentration was 1 or 2 µM. Aggregation was monitored by measuring the turbidity at 400 nm using a Perkin-Elmer Lambda Bio units/V spectrophotometer (Norwalk, CT) at 25°C.
| RESULTS |
|---|
|
|
|---|
|
-CD, the aggregation was slightly inhibited at low concentrations, greatly increased at the 25 mM concentration, and then gradually inhibited at concentrations above 25 mM. For HP-ß-CD, as the concentration was increased, the aggregation of aminoacylase was significantly prevented in a concentration-dependent manner. HP-
-CD inhibited the aminoacylase aggregation with the highest efficiency achieved when the concentration of HP-
-CD reached 50 mM. Surprisingly, at a high concentration (150 mM) although the aggregation rate was gradually reduced by the addition of HP-
-CD, the degree of aggregation reached a level similar to that of the control after 600-s incubation. Among the three HPCDs, HP-ß-CD reduced the turbidity of refolding aminoacylase most effectively, and 75150 mM HP-ß-CD could almost completely inhibit protein aggregation. When aminoacylase concentration in the refolding buffer increased from 1 to 2 µM, the efficiency of the three HPCDs to suppress aggregation was much smaller than the conditions with 1 µM enzyme (Fig. 3). However, the concentration-dependent manners of the three HPCDs were similar to those in Fig. 2. The results in Fig. 3 suggested that at low concentrations, the HPCDs were aggregation promoters and HP-
-CD was the most effective one. These results from aggregation experiments revealed that the three HPCDs might work by a much more complex mechanism than that proposed previously (17
|
|
36% of the native enzyme, which is quite consistent with results reported in the literature (7
66% of that of native enzyme when the concentration of HP-ß-CD was 75 mM. The effect of HP-
-CD was similar to HP-ß-CD at concentrations below 50 mM. However, the reactivation reached a maximum at
25 mM HP-
-CD, and the activity of aminoacylase recovered to
52% of that of the native enzyme in the presence of 75 mM HP-
-CD. For HP-
-CD, similar to its effect on protein aggregation, a significant decrease of the reactivity of aminoacylase was observed in the presence of 25 mM HP-
-CD, and then the activity of the enzyme was slightly enhanced to
44% with the addition of 75 mM HP-
-CD.
|
-CD decreased the fast phase rate constant
23-fold but had no significant effect on the slow phase rate constant. In contrast, the addition of HP-
-CD did not affect the fast phase rate constant but slightly increased the slow phase rate constant (approximately twofold). As a control, we also performed reactivation kinetic studies by using osmolytes as dilution additives as those described in our previous work (34
|
]222). As shown in the inset of Fig. 5, the results indicated that as concentration increased, the three HPCDs had different behavior in the secondary structure recovery of aminoacylase. For HP-ß-CD, [
]222 decreased very quickly as the concentration of HP-ß-CD increased to 10 mM and then decreased slowly as HP-ß-CD concentration increased. For HP-
-CD, [
]222 did not change significantly at low concentrations of HP-
-CD (<10 mM) but then decreased continuously as the concentration increased. The behavior of HP-
-CD was more complicated. With increasing HP-
-CD concentration, [
]222 slightly decreased at first, then increased gradually at a concentration of 25 mM, and finally decreased slowly. Consistent with the aggregation and reactivation studies, HP-ß-CD was the most efficient in assisting aminoacylase to recover its native secondary structures, and the ellipticity could be recovered to
60% of the native enzyme in the presence of 75 mM HP-ß-CD.
|
333.5 nm, whereas that of the denatured enzyme was at
349 nm. In the absence of HPCDs, Emax could be recovered to 338 nm. A slight blue shift from 338 to 336.5 nm was observed when the concentration of HP-ß-CD increased to 25 mM. With increasing HP-
-CD concentrations up to 75 mM, Emax blue shifted to 335.5 nm. For HP-
-CD, Emax red shifted to 338.5 nm at a concentration of 25 mM and then blue shifted to 337 nm, proving that HP-
-CD has little effect on the recovery of aminoacylase's tertiary structures. It might be worth noting that HP-ß-CD red shifted the emission maximum of free Trp (Fig. 1), whereas HP-
- and
-CD did not. Thus the results of HP-ß-CD might be composed of both protein conformational changes and the effects of HP-ß-CD. However, considering that HP-ß-CD had little effect on native enzyme (data not shown), it is safe to conclude that the results in Fig. 6 A were dominated by the conformational changes of the enzyme.
|
-CD > HP-
-CD. This result was quite consistent with the studies using free Trp as shown in Fig. 1. Furthermore, this result also indicated that although no significant effects were observed for HP-
-CD and HP-
-CD on free Trp, these two HPCDs also had the ability to bind with the hydrophobic regions of proteins. The results in Figs. 5 and 6 A also suggested that the refolded solutions contained considerable amounts of nonnative structures. The presence of all three HPCDs could successfully reduce the hydrophobic exposure of these nonnative species, as indicated by Fig. 6 B, and thus protect them against aggregation. | DISCUSSION |
|---|
|
|
|---|
The ability of various cyclodextrin derivatives to prevent protein aggregation varied significantly in previous investigations (17
,19
,33
,44
,45
). It is believed that the binding of the "host" cyclodextrin derivatives with the aromatic side chains of the "guest" proteins is crucial for its ability to assist protein refolding. Thus the numbers of aromatic residues and their locations in proteins might play a crucial role in investigating the effects of cyclodextrins. Table 2 summarizes the effects of cyclodextrins on different proteins in literature and the numbers of aromatic residues of these proteins. Although only limited numbers of proteins have been studied, a preliminary hypothesis could be proposed. That is, ß-cyclodextrins were the most efficient of the cyclodextrin derivatives when the proteins contained high content of aromatic residues (>0.1), whereas
-cyclodextrins were the best when the proteins contained low content of aromatic residues (<0.1). Moreover, the effects of HPCDs were also found to be dependent on both cyclodextrin and protein concentrations. This might be one of the reasons different effects of cyclodextrins were observed for different proteins.
|
-CD could alter the reactivation kinetics of aminoacylase (Table 1). This property seems to be specific to cyclodextrins, which was supported by the observation that no similar effect was found for osmolytes (Table 1) and surfactants (5
Based on the results in previous studies (7
,26
), the refolding pathway of aminoacylase was proposed to be a multistate process, as shown in Scheme 1. For such a multistate process, the observation might be complicated by the effects of cyclodextrins on the transition from the unfolded state (U) to the intermediate (I), from I to the native state (N), and from I to the aggregates (A). It might be worth noting that most of the aromatic residues might be exposed to water in the unfolded state and the intermediate state has limited numbers of exposed aromatic residues, whereas the native state contains only the exposed residues located on the surface. Thus in general, cyclodextrin has few effects on the native state of proteins. At low concentrations of cyclodextrin, only parts of the aromatic side chains of proteins in the unfolded state could be masked by cyclodextrin molecules, which may not significantly affect k1. Since the number of exposed aromatic residues in the intermediate state is much smaller than that of the unfolded state, the addition of low concentrations of cyclodextrin may lead to decrease of k2 and kA. The decrease of k2 and kA further results in an accumulation of the aggregation-prone intermediate state. Thus cyclodextrin may act as an aggregation promoter at low concentrations, which was observed in Figs. 2 and 3. At high concentrations, cyclodextrin could affect all the transitions, and the observation was dependent on the nature of the refolding kinetics and the binding constant of cyclodextrin. If the transition rates of U to I and I to A are slowed down, the aggregation may be gradually suppressed. This may explain the suppression effects of HPCDs under moderate concentrations. If the transition rate of I to N* was affected the most, an accumulation of the aggregation-prone intermediate state I would result in more off-pathway aggregates. This may explain the opposite effects of 75 and 150 mM HP-
-CD shown in Figs. 2 and 3. These theoretical analyses could be further supported if refolding kinetics could be obtained. Unfortunately, no refolding kinetic data could be obtained for the refolding of aminoacylase due to severe aggregation. However, the reactivation kinetics clearly showed that cyclodextrin could slow down the reactivation rate.
|
and
-CD, the binding is rather weak compared to HP-ß-CD (see Fig. 1 and 19
and
-CD could also prevent aggregation and assist aminoacylase reactivation. This suggested that besides the interactions between the cyclodextrin cavity and the aromatic residues, there are other interactions including the incorporation of linear hydrophobic side chains into the cyclodextrin cavity, the transient interaction between the aromatic side chains and the cavity edge, and the transient interaction between the surface of the protein and the hydrophilic exterior rims of the cyclodextrin (its oligosaccharide nature). This conclusion is supported by the results from ANS spectra (see Fig. 6 B), which suggested that the hydrophobic exposure in the refolded solutions was significantly protected by the addition of all of the three HPCDs, whereas the corresponding CD and intrinsic fluorescence spectra (Figs. 5 and 6 A) indicated that considerable amounts of unstructured species were present. Although it is difficult to distinguish the different types of interactions in this research, the fact that HP-
-CD did not affect the reactivation kinetics but also gradually increased the refolding yield indicated that these interactions also contributed to the ability to assist protein refolding. Moreover, the similar effects of HP-ß- and
-CD on the reactivation kinetics (Table 1) suggested that the ability to bind with the aromatic side chains only partially contributed to the effect of HPCDs. This may also explain why the substituents on the cyclodextrin ring were very important in determining its ability to assist the refolding of proteins (18In conclusion, among the various cyclodextrin derivatives, the relatively strong interaction between aromatic residues and the cavity of ß-cyclodextrins may present a very suitable system to suppress aggregation during refolding. Besides this specific interaction, other transient interactions may also contribute to the efficiency of cyclodextrins. Although the different effects of cyclodextrins on the rate of the different transition stages during protein refolding may complicate the prediction of the final results, the addition of moderate concentrations of cyclodextrins is expected to enhance the refolding yield of proteins. The results herein also suggested that cyclodextrins might work by a quite different mechanism from the well-established ones of osmolytes, surfactants, and chaperones.
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
Submitted on January 25, 2006; accepted for publication April 6, 2006.
| REFERENCES |
|---|
|
|
|---|
2. Middelberg, A. P. J. 2002. Preparative protein refolding. Trends Biotechnol. 20:437443.[CrossRef][Medline]
3. Tsumoto, K., D. Ejima, I. Kumagai, and T. Arakawa. 2003. Practical considerations in refolding proteins from inclusion bodies. Protein Expr. Purif. 28:18.[CrossRef][Medline]
4. Tandon, S., and P. Horowitz. 1986. Detergent-assisted refolding of guanidinium chloride-denatured rhodanese. The effect of lauryl maltoside. J. Biol. Chem. 261:1561515618.
5. Cleland, J. L., and T. W. Randolph. 1992. Mechanism of polyethylene glycol interaction with the molten globule folding intermediate of bovine carbonic anhydrase B. J. Biol. Chem. 267:31473153.
6. Gething, M. J., and J. Sambrook. 1992. Protein folding in the cell. Nature. 355:3345.[CrossRef][Medline]
7. Xie, Q., and H. M. Zhou. 2004. Refolding intermediate of guanidine hydrochloride denatured aminoacylase. Int. J. Biochem. Cell Biol. 36:13321340.[CrossRef][Medline]
8. Tandon, S., and P. Horowitz. 1988. The effects of lauryl maltoside on the reactivation of several enzymes after treatment with guanidinium chloride. Biochim. Biophys. Acta. 955:1925.[CrossRef][Medline]
9. Wetlaufer, D. B., and Y. Xie. 1995. Control of aggregation in protein refolding: a variety of surfactants promote renaturation of carbonic anhydrase II. Protein Sci. 4:15351543.[Abstract]
10. Meng, F. G., Y. K. Hong, H. W. He, A. E. Lyubarev, B. I. Kurganov, Y. B. Yan, and H. M. Zhou. 2004. Osmophobic effect of glycerol on irreversible thermal denaturation of rabbit creatine kinase. Biophys. J. 87:22472254.
11. Ou, W. B., Y. D. Park, and H. M. Zhou. 2002. Effect of osmolytes as folding aids on creatine kinase refolding pathway. Int. J. Biochem. Cell Biol. 34:136147.[CrossRef][Medline]
12. Singh, R., I. Haque, and F. Ahmad. 2005. Counteracting osmolyte trimethylamine N-oxide destabilizes proteins at pH below its pK(a). Measurements of thermodynamic parameters of proteins in the presence and absence of trimethylamine N-oxide. J. Biol. Chem. 280:1103511042.
13. Szejtli, J. 1998. Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 98:17431753.[CrossRef][Medline]
14. Uekama, K., F. Hirayama, and T. Irie. 1998. Cyclodextrin drug carrier systems. Chem. Rev. 98:20452076.[CrossRef][Medline]
15. Khan, A. R., P. Forgo, K. J. Stine, and V. T. D'Souza. 1998. Methods for selective modifications of cyclodextrins. Chem. Rev. 98:19771996.[CrossRef][Medline]
16. Davis, M. E., and M. E. Brewster. 2004. Cyclodextrin-based pharmaceutics: past, present and future. Nat. Rev. Drug Discov. 3:10231035.[CrossRef][Medline]
17. Karuppiah, N., and A. Sharma. 1995. Cyclodextrins as protein folding aids. Biochem. Biophys. Res. Commun. 211:6066.[CrossRef][Medline]
18. Sharma, L., and A. Sharma. 2001. Influence of cyclodextrin ring substituents on folding-related aggregation of bovine carbonic anhydrase. Eur. J. Biochem. 268:24562463.[Medline]
19. Otzen, D. R., B. R. Knudsen, F. Aachmann, K. L. Larsen, and R. Wimmer. 2002. Structural basis for cyclodextrins' suppression of human growth hormone aggregation. Protein Sci. 11:17791787.
20. Aachmann, F. L., D. E. Otzen, K. L. Larsen, and R. Wimmer. 2003. Structural background of cyclodextrin-protein interactions. Protein Eng. 16:905912.
21. Khajehpour, M., T. Troxler, V. Nanda, and J. M. Vanderkooi. 2004. Melittin as model system for probing interactions between proteins and cyclodextrins. Proteins. 55:275287.[Medline]
22. Anders, M. W., and W. Dekant. 1994. Aminoacylases. Adv. Pharmacol. 27:431448.
23. Birnbaum, S. M. 1955. Aminoacylase, amino acid acylase I and II from hog kidney. Methods Enzymol. 2:115119.[Medline]
24. Kordel, W., and F. Schneider. 1976. Chemical investigation on pig kidney aminoacylase. Biochim. Biophys. Acta. 445:446457.[Medline]
25. Kordel, W., and F. Schneider. 1976. Chemical modification of two tryptophan residues abolishes the catalytic activity of aminoacylase. Hoppe Seylers Z. Physiol. Chem. 357:11091115.[Medline]
26. Wang, H. R., T. Zhang, and H. M. Zhou. 1995. Comparison of inactivation and conformational changes of aminoacylase during guanidinium chloride denaturation. Biochim. Biophys. Acta. 1248:97106.[Medline]
27. Wang, H., X. Wang, T. Zhang, and H. M. Zhou. 1995. Comparison between conformational change and inactivation rates of aminoacylase during denaturation in urea solutions. Sci. China B. 38:328335.[Medline]
28. He, B., M. Yan, T. Zhang, and H. M. Zhou. 1994. Unfolding and inactivation during thermal denaturation of aminoacylase. Chin. Sci. Bull. 39:11221127.
29. He, B., Y. Zhang, T. Zhang, H. R. Wang, and H. M. Zhou. 1995. Inactivation and unfolding of aminoacylase during denaturation in sodium dodecyl sulfate solutions. J. Protein Chem. 14:349357.[CrossRef][Medline]
30. He, B., T. Zhang, and H. M. Zhou. 1997. Comparison of inactivation and conformational changes of aminoacylase during denaturation in lithium dodecylsulphate solutions. Int. J. Biol. Macromol. 20:5362.[Medline]
31. He, H. W., J. Zhang, H. M. Zhou, and Y. B. Yan. 2005. Conformational change in the C-terminal domain is responsible for the initiation of creatine kinase thermal aggregation. Biophys. J. 89:26502658.
32. Burstein, E. A., S. M. Abornev, and Y. K. Reshetnyak. 2001. Decomposition of protein tryptophan fluorescence spectra into log-normal components. I. Decomposition algorithms. Biophys. J. 81:16991709.
33. Qin, X. R., H. Abe, and H. Nakanishi. 2002. NMR and CD studies on the interaction of Alzheimer ß-amyloid peptide (1228) with ß-cyclodextrin. Biochem. Biophys. Res. Commun. 297:10111015.[CrossRef][Medline]
34. Kim, S. H., Y. B. Yan, and H. M. Zhou. 2006. Role of osmolytes as chemical chaperones during the refolding of aminoacylase. Biochem. Cell Biol. 84:3038.[CrossRef][Medline]
35. Marston, F. A. 1986. The purification of eukaryotic polypeptides synthesized in Escherichia coli. Biochem. J. 240:112.[Medline]
36. Dill, K. A. 1990. Dominant forces in protein folding. Biochemistry. 31:1234512352.
37. Chi, E. Y., S. Krishnan, T. W. Randolph, and J. F. Carpenter. 2003. Physical stability of proteins in aqueous solutions: mechanism and driving forces in nonnative protein aggregation. Pharm. Res. 20:13251336.[CrossRef][Medline]
38. Rozema, D., and S. H. Gellman. 1995. Artificial chaperones: protein refolding via sequential use of detergent and cyclodextrin. J. Am. Chem. Soc. 117:23732374.[CrossRef]
39. Timasheff, S. N. 1998. Control of protein stability and reactions by weakly interacting cosolvents: the simplicity of the complicated. Adv. Protein Chem. 51:355432.[Medline]
40. Bolen, D. W. 2001. Protein stabilization by naturally occurring osmolytes. Methods Mol. Biol. 168:1736.[Medline]
41. Khodarahmi, R., and R. Yazdanparast. 2004. Refolding of chemically denatured alpha-amylase in dilution additive mode. Biochim. Biophys. Acta. 1674:175181.[Medline]
42. Tavornvipas, S., S. Tajiri, F. Hirayama, H. Arima, and K. Uekama. 2004. Effects of hydrophilic cyclodextrins on aggregation of recombinant human growth hormone. Pharm. Res. 21:23692376.[Medline]
43. Mishra, R., R. Seckler, and R. Bhat. 2005. Efficient refolding of aggregation prone citrate synthase by polyol osmolytes: how well are protein folding and stability aspects coupled? J. Biol. Chem. 280:1555315560.
44. Bär, J., R. Golbik, G. Hübner, and G. Kopperschläger. 2000. Denaturation of phosphofructokinase-1 from Saccharomyces cerevisiae by guanidinium chloride and reconstitution of the unfolded subunits to their catalytically active form. Biochemistry. 39:69606968.[CrossRef][Medline]
45. Davis, A. J., I. Y. Perera, and W. F. Boss. 2004. Cyclodextrins enhance recombinant phosphatidylinositol phosphate kinase activity. J. Lipid Res. 45:17831789.
46. ten Wolde, P. R., and D. Chandler. 2002. Drying-induced hydrophobic polymer collapse. Proc. Natl. Acad. Sci. USA. 99:65396543.
This article has been cited by other articles:
![]() |
J.-T. Su, S.-H. Kim, and Y.-B. Yan Dissecting the Pretransitional Conformational Changes in Aminoacylase I Thermal Denaturation Biophys. J., January 15, 2007; 92(2): 578 - 587. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |